Highlights
NASDAQ: DERM       Dermira Inc
Last Price Today's Change   Day's Range   Trading Volume
19.155   +0.005 (0.03%)  19.13 - 19.21  3,246,400

Overview

 
Avg Volume (4 weeks):3,615,988
4 Weeks Range:12.50 - 19.48
4 Weeks Price Volatility (%):
95.34%
52 Weeks Range:5.25 - 19.48
52 Weeks Price Volatility (%):
97.72%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Dermira Inc is a biopharmaceutical company focuses on the development and commercialization of medical dermatology products to dermatologists and their patients primarily in the United States.The company's late-stage product candidates include Cimzia, an injectable biologic tumor necrosis factor-alpha inhibitor to treat various inflammatory diseases, as well as to treat patients with moderate-to-severe chronic plaque psoriasis; Glycopyrronium tosylate, a small-molecule anticholinergic product that is in Phase III clinical trial for the treatment of primary axillary hyperhidrosis or excessive underarm sweating; and Olumacostat glasaretil, a small-molecule sebum inhibitor, which is in Phase III clinical trial to treat acne vulgaris or acne.

  Be the first to like this.
 


 

3414  4674  636  186 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 NIO 4.67+0.30 
 TTNP 0.334+0.084 
 SPY 331.95+1.03 
 SNCA 1.60+0.35 
 EEM 46.23+0.26 
 AVP 5.60-0.05 
 AMD 50.93+1.16 
 CHK 0.661-0.029 
 BAC 34.71-0.01 
 GE 11.81-0.03 
Partners & Brokers